PITFALLS OF IMMUNOTHERAPY: LESSONS FROM A PATIENT WITH CTLA-4 HAPLOINSUFFICIENCY

被引：0
|
作者：
Watson, Leisa R. [1 ]
Slade, Charlotte A. [2 ,3 ,4 ]
Ojaimi, Samar [1 ,5 ]
Barnes, Sara [1 ,5 ]
Fedele, Pasquale [2 ,3 ,6 ]
Smith, Prudence [6 ]
Marum, Justine [7 ]
Lunke, Sebastian [7 ,8 ]
Stark, Z. [7 ,9 ]
Hunter, Matthew F. [10 ,11 ]
Bryant, Vanessa L. [2 ,3 ,4 ]
Low, Michael S. Y. [1 ,2 ,3 ,6 ]
机构：
[1] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia
[2] Walter & Eliza Hall Inst Med Res, Immunol Div, 1G Royal Parade, Parkville, Vic, Australia
[3] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia
[4] Royal Melbourne Hosp, Dept Clin Immunol & Allergy, Parkville, Vic, Australia
[5] Monash Hlth, Dept Immunol & Allergy, 246 Clayton Rd, Clayton, Vic, Australia
[6] Monash Hlth, Monash Haematol, 246 Clayton Rd, Clayton, Vic, Australia
[7] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, 50 Flemington Rd, Parkville, Vic, Australia
[8] Univ Melbourne, Dept Pathol, Parkville, Vic, Australia
[9] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia
[10] Monash Hlth, Monash Genet, 246 Clayton Rd, Clayton, Vic, Australia
[11] Monash Univ, Dept Paediat, Melbourne, Vic, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2018年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P55
引用
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [41] Targeting the alternatively spliced soluble isoform of CTLA-4: prospects for immunotherapy?
    Ward, Frank J.
    Dahal, Lekh N.
    Khanolkar, Rahul C.
    Shankar, Sucharita P.
    Barker, Robert N.
    IMMUNOTHERAPY, 2014, 6 (10) : 1073 - 1084
  • [42] CTLA-4 blockade-based immunotherapy for prostate cancer.
    Fong, L
    Rini, B
    Kavanaugh, B
    Small, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 185S - 185S
  • [43] CTLA-4 Detection in Malignant Mesothelioma Tissues and in Effusions: Relevance for Immunotherapy
    Fedeli, Franco
    Varesano, Serena
    Ferro, Paola
    Franceschini, Maria Cristiana
    Salvi, Sandra
    Boccardo, Siniona
    Ravetti, Jean Louis
    Morabito, Anna
    Valentino, Alessandro
    Roncella, Silvio
    Pistillo, Maria Pia
    MODERN PATHOLOGY, 2016, 29 : 469A - 470A
  • [44] Late CTLA-4 Ig treatment improves antitumor efficacy of immunotherapy
    Mok, Stephen
    Allison, James P.
    CANCER RESEARCH, 2022, 82 (12)
  • [45] CTLA-4 Detection in Malignant Mesothelioma Tissues and in Effusions: Relevance for Immunotherapy
    Fedeli, Franco
    Varesano, Serena
    Ferro, Paola
    Franceschini, Maria Cristiana
    Salvi, Sandra
    Boccardo, Simona
    Ravetti, Jean Louis
    Morabito, Anna
    Valentino, Alessandro
    Roncella, Silvio
    Pistillo, Maria Pia
    LABORATORY INVESTIGATION, 2016, 96 : 469A - 470A
  • [46] Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy
    Liu, Yang
    Zheng, Pan
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (01) : 4 - 12
  • [47] Immunotherapy via CTLA-4 blockade with humab MDX-010
    Lowy, I
    ANNALS OF ONCOLOGY, 2005, 16 : 25 - 25
  • [48] KIR CTLA-4
    Genes & Immunity, 2005, 6 (Suppl 1): : S2 - S4
  • [49] CTLA-4 HAPLOINSUFFICIENCY PRESENTING AS ACUTE MYELITIS DUE TO NONMALIGNANT LYMPHOCYTIC INFILTRATION OF THE SPINAL CORD
    Lin, S.
    Uzel, G.
    Pittaluga, S.
    Bayerl, M.
    Specht, C.
    Fausnight, T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S77 - S77
  • [50] CTLA-4: From mechanism to autoimmune therapy
    Hosseini, Arezoo
    Gharibi, Tohid
    Marofi, Faroogh
    Babaloo, Zohreh
    Baradaran, Behzad
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 80
12345